In a new study, researchers investigated whether molecular profiling could predict clinical outcomes, and found that patients with primary malignant melanoma are at a higher risk of recurrent disease if they present mutations in two or more cancer-related genes. The study’s results were recently presented at the 2016 HemOnc Today Melanoma and Cutaneous Malignancies meeting.
MRV Research
Microneedle patch delivers localized cancer immunotherapy to melanoma
Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a technique that uses a patch embedded with microneedles to deliver cancer immunotherapy treatment directly to the site of melanoma skin cancer.
Lower Vitamin D Levels Linked to Poorer Melanoma Outcomes
Lower vitamin D levels were associated with poorer overall survival, melanoma-specific survival, and disease-free survival independent of a strong association between lower vitamin D and higher C-reactive protein, a study published in the Journal of Clinical Oncology has shown.1
Team achieves breakthrough in diagnosis of melanoma skin cancer
In collaboration with researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and a non-coding RNA gene called SAMMSON. The SAMMSON gene is specifically expressed in human malignant melanoma and, strikingly, the growth of aggressive skin cancer is highly dependent on this gene.